Hemophilia A Common Mutation Screening Factor VIII Intron 22 Inversion Analysis
Introduction to the Test
The Hemophilia A Common Mutation Screening Factor VIII Intron 22 Inversion analysis is a specialized genetic test designed to identify specific mutations in the Factor VIII gene that are associated with Hemophilia A. This condition is a bleeding disorder that results from deficiencies in clotting factors, leading to excessive bleeding and complications. Early diagnosis through this screening is crucial for effective management and treatment of the disorder.
What the Test Measures
This test specifically detects the Intron 22 inversion mutation in the Factor VIII gene, which is one of the most common genetic causes of Hemophilia A. By identifying this mutation, healthcare providers can assess the risk of bleeding disorders and tailor treatment plans accordingly.
Who Should Consider This Test?
Individuals who may benefit from this test include:
- Those with a family history of Hemophilia A.
- Patients presenting with unexplained bleeding or bruising.
- Individuals undergoing pre-surgical evaluations where bleeding risks need to be assessed.
If you exhibit symptoms such as prolonged bleeding after injury, frequent nosebleeds, or easy bruising, it is advisable to consult a healthcare provider about this screening.
Benefits of Taking the Test
The benefits of the Hemophilia A Common Mutation Screening include:
- Early detection of Hemophilia A, allowing for timely intervention.
- Informed decision-making regarding treatment options.
- Risk assessment for family members and potential carriers of the mutation.
By understanding your genetic predisposition, you can better manage your health and prevent complications related to bleeding disorders.
Understanding Your Results
Results from the Hemophilia A screening will indicate whether the Intron 22 inversion mutation is present. A positive result suggests a higher risk for developing Hemophilia A, while a negative result indicates that this specific mutation is not present. It is essential to discuss your results with a healthcare provider for comprehensive understanding and next steps.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Hemophilia A Common Mutation Screening Factor VIII Intron 22 Inversion Analysis | 24,000 KSh | 32,000 KSh |
Booking Information
We have branches across all major cities in Kenya and offer home sample collection services for your convenience. To book your test or for more information, please call or WhatsApp us at +254746849631. Don’t wait—take control of your health today!
Pre-Test Instructions
The Hemophilia A Common Mutation Screening can be performed with a Doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or for individuals planning to travel abroad.
Turnaround Time and Sample Type
The expected turnaround time for results is 10-11 days, and the sample type required is peripheral blood collected in an EDTA Vacutainer (2ml).
